Salud financiera de hoja de balance de Kilitch Drugs (India)
Salud financiera controles de criterios 3/6
Kilitch Drugs (India) tiene un patrimonio de accionistas total de ₹1.8B y una deuda total de ₹316.5M, lo que sitúa su ratio deuda-patrimonio en 18%. Sus activos y pasivos totales son ₹2.4B y ₹643.9M respectivamente. El BAIT de Kilitch Drugs (India) es de ₹208.1M, por lo que su ratio de cobertura de intereses es de 3.5. Tiene efectivo e inversiones a corto plazo que ascienden a ₹690.7M.
Información clave
18.0%
Ratio deuda-patrimonio
₹316.47m
Deuda
| Ratio de cobertura de intereses | 2.6x |
| Efectivo | ₹690.71m |
| Patrimonio | ₹1.76b |
| Total pasivo | ₹643.88m |
| Activos totales | ₹2.40b |
Actualizaciones recientes sobre salud financiera
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03
Recent updates
Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar
Jul 23Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump
Feb 02We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease
Jan 30Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings
Nov 17Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why
Sep 23These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors
May 05Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today
Apr 08These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 13Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?
Aug 20Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹1.5B) de KILITCH superan a sus pasivos a corto plazo (₹642.2M).
Pasivo a largo plazo: Los activos a corto plazo de KILITCH (₹1.5B) superan a sus pasivos a largo plazo (₹1.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: KILITCH tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de KILITCH ha crecido de 7.7% a 18% en los últimos 5 años.
Cobertura de la deuda: El flujo de caja operativo de KILITCH es negativo, por lo que la deuda no está bien cubierta.
Cobertura de intereses: Los pagos de intereses de la deuda de KILITCH no están bien cubiertos por el BAIT (3x cobertura).